πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Lxo Ireland Designated Patents

Full USPTO pharma patent portfolio for Lxo Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
201
Expiring ≀24m
3

Quick answer

Lxo Ireland Designated has 201 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months β€” use filters for patent-cliff planning.

Page 2 of 5

  1. US 10391157

    Materials and methods for producing improved lentiviral vector particles

    Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10391164

    Vaccines for HSV-2

    Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10377772

    Macrocyclic LRRK2 kinase inhibitors

    Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10369118

    Method of reducing scarring

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10342815

    GLA monotherapy for use in cancer treatment

    Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10273292

    Non-HIV vaccine antigen from the vaginal microbiota capable of inducing a mucosal neutralizing protective antibody response against HIV infection

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10238735

    Controlled activation of complement components for use as endogenous adjuvant

    Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10179919

    Multigenome retroviral vector preparations and methods and systems for producing and using same

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10144753

    Anthracycline derivatives for treating tumor diseases

    Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10124109

    Method and device for treating allergic reactions and difficult-to-manage respiratory diseases

    Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10099995

    Resveratrol esters

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10086086

    Payload molecule delivery using molecular rebar

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10085951

    Curcuminoid formulations and related methods of treatment

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10081632

    Substituted tetrahydropyrido[3β€²,2β€²:4,5]pyrrolo[1,2-Ξ±]pyrazine-2-carboxamides as RSK inhibitors

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10071358

    Antibiotic preparation method and platform system based on same

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10028946

    Treating pain in patients with hepatic impairment

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9993765

    Portable oxygen enrichment device and method of use

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9895435

    Vaccines for HSV-2

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9789057

    Pharmaceutical delivery system

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9771366

    Substituted tetrahydropyrido[3β€²,2β€²:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitors

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9717679

    Methods for the prevention and treatment of animal skin conditions

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9717672

    Compositions and methods for UV-curable cosmetic nail coatings

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9713585

    Nail coatings having enhanced adhesion

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9713635

    Materials and methods for producing improved lentiviral vector particles

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9670473

    Crystals of angiotensin-converting enzyme (ACE)

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9636649

    Dispersions comprising discrete carbon nanotube fibers

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9592180

    Method and device for treating allergic reactions and difficult-to-manage respiratory diseases

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9586975

    Macrocyclic salt-inducible kinase inhibitors

    Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9566250

    Artificial tissue constructs comprising alveolar cells and methods for using the same

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9555099

    Vaccines for HSV-2

    Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9541545

    Fluorescent neutralization and adherence inhibition assays

    Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9498468

    Rhinitis treatment regimens

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9493626

    Dispersions comprising discrete carbon nanotube fibers

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9492781

    Portable oxygen enrichment device and method of use

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9446121

    Cloning of honey bee allergen

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9434933

    Crystal

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9422413

    Elastomer formulations comprising discrete carbon nanotube fibers

    Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9370519

    Macrocyclic FLT3 kinase inhibitors

    Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9359429

    Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof

    Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9353240

    Elastomer formulations comprising discrete carbon nanotube fibers

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9248113

    Infusion and injection solution of Levodopa

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9212273

    Elastomer formulations

    Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9096609

    Macrocyclic LRRK2 kinase inhibitors

    Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9090630

    Macrocyclic FLT3 kinase inhibitors

    Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9073989

    Antibiotic comprising an antibody mimetic, its preparation methods and uses thereof

    Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9044420

    Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9018238

    Inhibitor of casein kinase 1Ξ΄ and casein kinase 1Ξ΅

    Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8962593

    GLA monotherapy for use in cancer treatment

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Lxo Ireland Designated have?

201 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Lxo Ireland Designated patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.